Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 4
2004 8
2005 3
2006 1
2007 5
2008 8
2009 7
2010 7
2011 8
2012 7
2013 7
2014 4
2015 10
2016 13
2017 6
2018 4
2019 5
2020 4
2021 8
2022 5
2023 12
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

124 results

Results by year

Filters applied: . Clear all
Page 1
Tumor-infiltrating lymphocyte treatment for anti-PD-1-resistant metastatic lung cancer: a phase 1 trial.
Creelan BC, Wang C, Teer JK, Toloza EM, Yao J, Kim S, Landin AM, Mullinax JE, Saller JJ, Saltos AN, Noyes DR, Montoya LB, Curry W, Pilon-Thomas SA, Chiappori AA, Tanvetyanon T, Kaye FJ, Thompson ZJ, Yoder SJ, Fang B, Koomen JM, Sarnaik AA, Chen DT, Conejo-Garcia JR, Haura EB, Antonia SJ. Creelan BC, et al. Among authors: chen dt. Nat Med. 2021 Aug;27(8):1410-1418. doi: 10.1038/s41591-021-01462-y. Epub 2021 Aug 12. Nat Med. 2021. PMID: 34385708 Free PMC article. Clinical Trial.
Combined nivolumab and ipilimumab with or without stereotactic body radiation therapy for advanced Merkel cell carcinoma: a randomised, open label, phase 2 trial.
Kim S, Wuthrick E, Blakaj D, Eroglu Z, Verschraegen C, Thapa R, Mills M, Dibs K, Liveringhouse C, Russell J, Caudell JJ, Tarhini A, Markowitz J, Kendra K, Wu R, Chen DT, Berglund A, Michael L, Aoki M, Wang MH, Hamaidi I, Cheng P, de la Iglesia J, Slebos RJ, Chung CH, Knepper TC, Moran-Segura CM, Nguyen JV, Perez BA, Rose T, Harrison L, Messina JL, Sondak VK, Tsai KY, Khushalani NI, Brohl AS. Kim S, et al. Among authors: chen dt. Lancet. 2022 Sep 24;400(10357):1008-1019. doi: 10.1016/S0140-6736(22)01659-2. Epub 2022 Sep 12. Lancet. 2022. PMID: 36108657 Free PMC article. Clinical Trial.
Overview of approaches to estimate real-world disease progression in lung cancer.
Amorrortu R, Garcia M, Zhao Y, El Naqa I, Balagurunathan Y, Chen DT, Thieu T, Schabath MB, Rollison DE. Amorrortu R, et al. Among authors: chen dt. JNCI Cancer Spectr. 2023 Oct 31;7(6):pkad074. doi: 10.1093/jncics/pkad074. JNCI Cancer Spectr. 2023. PMID: 37738580 Free PMC article. Review.
Survivin Dendritic Cell Vaccine Safely Induces Immune Responses and Is Associated with Durable Disease Control after Autologous Transplant in Patients with Myeloma.
Freeman CL, Atkins R, Varadarajan I, Menges M, Edelman J, Baz R, Brayer J, Castaneda Puglianini O, Ochoa-Bayona JL, Nishihori T, Shain KH, Shah B, Chen DT, Kelley L, Coppola D, Alsina M, Antonia S, Anasetti C, Locke FL. Freeman CL, et al. Among authors: chen dt. Clin Cancer Res. 2023 Nov 14;29(22):4575-4585. doi: 10.1158/1078-0432.CCR-22-3987. Clin Cancer Res. 2023. PMID: 37735756
Osimertinib vs. afatinib as first-line treatment for patients with metastatic non-small cell lung cancer with an EGFR exon 19 deletion or exon 21 L858R mutation.
Gilardone S, Thapa R, Laborde J, Shafique M, Saltos A, Creelan B, Tanvetyanon T, Chiappori A, Simon G, Haura EB, Gray JE, Chen DT, Melzer D, Pellini B. Gilardone S, et al. Among authors: chen dt. J Thorac Dis. 2023 Nov 30;15(11):6115-6125. doi: 10.21037/jtd-23-686. Epub 2023 Nov 8. J Thorac Dis. 2023. PMID: 38090314 Free PMC article.
Phase 1 Dose Escalation of Stereotactic Body Radiation Therapy and Concurrent Cisplatin for Reirradiation of Unresectable, Recurrent Squamous Cell Carcinoma of the Head and Neck.
Echevarria MI, Yang GQ, Chen DT, Kirtane K, Russell J, Kish J, Muzaffar J, Otto K, Padhya T, McMullen C, Patel K, Chung CH, Caudell JJ. Echevarria MI, et al. Among authors: chen dt. Int J Radiat Oncol Biol Phys. 2023 Oct 1;117(2):341-347. doi: 10.1016/j.ijrobp.2023.04.007. Epub 2023 Apr 25. Int J Radiat Oncol Biol Phys. 2023. PMID: 37105404 Clinical Trial.
An miRNA Signature Predicts Grading of Pancreatic Neuroendocrine Neoplasms.
Saller J, White D, Hough B, Yoder S, Whiting J, Chen DT, Magliocco A, Coppola D. Saller J, et al. Among authors: chen dt. Cancer Genomics Proteomics. 2023 Mar-Apr;20(2):154-164. doi: 10.21873/cgp.20370. Cancer Genomics Proteomics. 2023. PMID: 36870693 Free PMC article.
PATH-SURVEYOR: pathway level survival enquiry for immuno-oncology and drug repurposing.
Obermayer AN, Chang D, Nobles G, Teng M, Tan AC, Wang X, Chen YA, Eschrich S, Rodriguez PC, Grass GD, Meshinchi S, Tarhini A, Chen DT, Shaw TI. Obermayer AN, et al. Among authors: chen dt. BMC Bioinformatics. 2023 Jun 28;24(1):266. doi: 10.1186/s12859-023-05393-y. BMC Bioinformatics. 2023. PMID: 37380943 Free PMC article.
Does histology really influence gastric cancer prognosis?
Luu C, Thapa R, Woo K, Coppola D, Almhanna K, Pimiento JM, Chen DT, Marquez DD, Hodul PJ. Luu C, et al. Among authors: chen dt. J Gastrointest Oncol. 2017 Dec;8(6):1026-1036. doi: 10.21037/jgo.2017.09.08. J Gastrointest Oncol. 2017. PMID: 29299363 Free PMC article.
124 results